glp-1 drugs for weight loss Popular medications may have health benefits that extend beyond and blood sugar control, a new study finds Amazon.com: GLP-1 Weight Loss -

Updated June 1, 2025

Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review

Some require measurement at the prescribing visit itself

[DOI] [PMC free article] [PubMed] [Google Scholar] 70.Xia L, Shen T, Dong W, Su F, Wang J, Wang Q, et al

Transition to Metabolic Constraint Collectively, GLP-1RA therapy is characterized by persistent reductions in nutrient inflow, increased reliance on lipid-derived substrates, suppression of anabolic pathways through AMPK signaling, and context-dependent modulation of adipose tissue lipolysis

Although its often spoken about as one thing, its consequences look different depending on the organ system involved: Metabolic organs (liver, adipose tissue, pancreas): Chronic inflammation here is associated with insulin resistance, higher glucose, and fatty liver disease. Blood vessels / cardiometabolic system: Inflammation contributes to long-term cardiovascular risk, and GLP-1 therapies improve several cardiometabolic risk factors, including blood pressure. Kidneys: Metabolic stress accelerates kidney damage and albuminuria